Osteoarthritis Pain Medicine Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Osteoarthritis Pain Medicine Market is anticipated to grow at a significant CAGR during the forecast period. The market growth is driven by the increasing prevalence of arthritis and the surge in the number of sports injuries. Among the types of osteoarthritis pain medicines, hand osteoarthritis medicines are likely to see a major boost in the future years owing to the constantly growing cases. The hand is the most frequently affected part of the body by osteoarthritis, which results in excessive pain and inability to properly function of hand or wrist. Osteoarthritis of the hand is most likely to develop in people falling in the age group of 40 to 70. As per the Arthritis Foundation, in the US, nearly 54.4 million adults (22.7% of all adults) had doctor-diagnosed arthritis during the period, 2013-2015. By 2040, an estimated adult aged 18 years and older with doctor-diagnosed arthritis will be 78.4 million (25.9% of the estimated total adult population) in the US. Osteoarthritis is the most common form of arthritis.
There are various forms of
medicines available such as analgesics, that are used for pain treatment. This
drug class works by stopping signals in the body that creates pain. Instances
of analgesics include Acetaminophen (Tylenol) and Duloxetine (Cymbalta).
Acetaminophen (Tylenol) is an over-the-counter (OTC) analgesic that can be
administered orally as a tablet, gel capsule, or liquid concentration. Another
class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) is also
used for the treatment of osteoarthritis pain. Moreover, a rise in
healthcare-related spending along with awareness related to osteoarthritis is
likely to open up new avenues of growth of the global osteoarthritis pain
medicine market during the forecast period.
To Request a Sample of our Report on Osteoarthritis Pain
Medicine Market: https://www.omrglobal.com/request-sample/osteoarthritis-pain-medicine-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2024-2030
Segment Covered-
·
By Product
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Pfizer
Inc., Johnson & Johnson Services, Inc., and GlaxoSmithKline plc, among
others.
Osteoarthritis Pain Medicine Market Report by Segment
By Product
• Oral
• Injection
A
full Report of Osteoarthritis Pain Medicine Market is Available @ https://www.omrglobal.com/industry-reports/osteoarthritis-pain-medicine-market
Osteoarthritis Pain Medicine Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment